10-K Decoder · All companies

Greenwich LifeSciences, Inc.

GLSI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Jun 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$19.4M−$17.6M−10.3%
Net income−$19.4M−$17.4M−11.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 16, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$5.90M−$3.70M−59.5%
Net income−$5.80M−$3.70M−56.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Greenwich LifeSciences's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Jun 2026.
Was Greenwich LifeSciences profitable in FY2025?
No: net income was −$19.4M and operating income −$19.4M in FY2025.
What was Greenwich LifeSciences's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 16, 2026.